-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Maintains Buy on Madrigal Pharmaceuticals, Raises Price Target to $670

Benzinga·12/11/2025 17:01:03
Listen to the news
B. Riley Securities analyst William Woods maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Buy and raises the price target from $560 to $670.